Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
Answer from: at Academic Institution
For IPF patients and those on IS meds, every 4 months, I obtain Spirometry and DLCO. I obtain six-minute walk tests every 4-6 months.
Comments
at Medical Center Pulmonary Consultants
3-6 months.
13806
Sign in or Register to read more
25137
Related Questions
What is the duration of steroids that you prescribe for organizing pneumonia?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Would you add abatacept to treat active inflammatory arthritis in a patient with history of RA-ILD who is already taking mycophenolate?
Would you consider adding or switching to pirfenidone for a patient with progressing UIP (based on imaging and PFTs) who is currently on nintedanib?
Is there a role for nintedanib in the management of patients with radiation-induced pulmonary fibrosis?
Have you adopted the use of low dose morphine for treatment of cough in patients with IPF?
How do you approach management of ILD in the presence of weakly positive RF and ANA but no other objective systemic findings of connective tissue disease?
How do you approach a patient with sarcoidosis who cannot tolerate steroids and who is developing ILD?
Would you consider using steroids in patients with respiratory failure caused by aspiration pneumonitis?
What dose and duration of steroid therapy do you employ while starting mycophenolate in an outpatient with relatively stable CTD-ILD?
3-6 months.